Heroin Addiction Clinical Trial
Official title:
Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches: A Study on Practicability With Patients Maintained With Daily Dosages Between 60mg and 100mg Methadone.
Buprenorphine is an important alternative to methadone in the maintenance treatment of heroin addiction. Transfer from methadone to buprenorphine requires a reduction of daily methadone dosage below 30 mg to avoid withdrawal after the first buprenorphine intake. The study hypothesis states that the transfer from a daily methadone dosage between 60 mg and 100 mg to buprenorphine can be carried out without withdrawal using buprenorphine patches (35 micro grams per hour) within 12 to 48 hours after last methadone intake.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02062723 -
Observational Study to Assess the Efficacy and Tolerability of Eptadone®, in Heroin Addicted Patients in a MMT
|
N/A | |
Completed |
NCT01580163 -
Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification
|
N/A | |
Completed |
NCT00574067 -
Buprenorphine for Prisoners
|
Phase 3 | |
Completed |
NCT00378079 -
Methadone Maintenance for Prisoners
|
Phase 3 | |
Completed |
NCT01457872 -
Malmö Treatment Referral and Intervention Study
|
N/A | |
Active, not recruiting |
NCT04086459 -
PET/MRI Study on the Neurological Mechanism of rTMS Treatment for Heroin Addiction
|
N/A | |
Recruiting |
NCT01093248 -
Methadone Maintenance Treatment Outcome Study in Taiwan
|
N/A | |
Completed |
NCT02062736 -
Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT.
|
N/A | |
Not yet recruiting |
NCT01668732 -
Decision Making Deficit and DNA Methylation in Opioid Receptor Genes Among Community Heroin Addicts
|
N/A |